Trustees Of Columbia University In The City Of New York Rapt Therapeutics, Inc. Transaction History
Trustees Of Columbia University In The City Of New York
- $631 Million
- Q1 2025
A detailed history of Trustees Of Columbia University In The City Of New York transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Trustees Of Columbia University In The City Of New York holds 73,383 shares of RAPT stock, worth $68,980. This represents 0.01% of its overall portfolio holdings.
Number of Shares
73,383
Previous 73,383
-0.0%
Holding current value
$68,980
Previous $115,000
22.61%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
134MCall Options Held
41.3KPut Options Held
100-
Medicxi Ventures Management (Jersey) LTD22.4MShares$21 Million7.04% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$12.3 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$12.3 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$11.8 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$11.1 Million0.24% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $27.9M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...